Treatment of neuromyelitis optica: Review and recommendations

Treatment of neuromyelitis optica: Review and recommendations

Показать другие версии (1)

Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...

Полное описание

Библиографические подробности
Главные авторы:	Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Isabel Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, De Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D, Guthy Jackson Charitable Foundation Clinical Consortium and Biorepository
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2012

Схожие документы

Treatment of Neuromyelitis Optica: Review and Recommendations.
по: Kimbrough, D, и др.
Опубликовано: (2012)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
по: Jyh Yung Hor, и др.
Опубликовано: (2020-06-01)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
по: Pittock, S, и др.
Опубликовано: (2019)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
по: Fujihara, K, и др.
Опубликовано: (2014)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
по: Collongues, N, и др.
Опубликовано: (2013)

The borderland of neuromyelitis optica.
по: Matthews, L, и др.
Опубликовано: (2009)

Neuromyelitis optica associated with systemic autoimmune diseases in children
по: Russo RA, и др.
Опубликовано: (2008-09-01)

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
по: Mealy, M, и др.
Опубликовано: (2014)

Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis
по: Douglas Kazutoshi Sato, и др.
Опубликовано: (2014-06-01)

Atypical presentations of neuromyelitis optica
по: Douglas Sato, и др.
Опубликовано: (2011-10-01)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
по: Kim, W, и др.
Опубликовано: (2012)

Use of mitoxantrone in neuromyelitis optica.
по: Kitley, J, и др.
Опубликовано: (2011)

Current and future treatment approaches for neuromyelitis optica
по: Nicolas Collongues, и др.
Опубликовано: (2011-03-01)

Treatment of neuromyelitis optica: an evidence based review
по: Douglas Sato, и др.
Опубликовано: (2012-01-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
по: Sung-Min Kim, и др.
Опубликовано: (2017-07-01)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
по: Nour, M, и др.
Опубликовано: (2014)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
по: Elsone, L, и др.
Опубликовано: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
по: Waters, P, и др.
Опубликовано: (2015)

Magnetic resonance imaging in neuromyelitis optica.
по: Tackley, G, и др.
Опубликовано: (2014)

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
по: Nicolas Collongues, и др.
Опубликовано: (2016-05-01)

Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort
по: Shervin Gholizadeh, и др.
Опубликовано: (2024-10-01)

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
по: Cree, BAC, и др.
Опубликовано: (2019)

A practical guide to the treatment of neuromyelitis optica.
по: Palace, J, и др.
Опубликовано: (2012)

The evolving clinical spectrum of neuromyelitis optica
по: Viegas, S, и др.
Опубликовано: (2008)

A mathematical model of cellular swelling in Neuromyelitis optica
по: Laranjeira, S, и др.
Опубликовано: (2017)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
по: Sato, D, и др.
Опубликовано: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
по: Matthews, L, и др.
Опубликовано: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
по: Matthews, L, и др.
Опубликовано: (2013)

Neuromyelitis Optica
по: Goyal V, и др.
Опубликовано: (2009-10-01)

Neuromyelitis optica
по: Jacob Anu, и др.
Опубликовано: (2007-01-01)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
по: Nour, M, и др.
Опубликовано: (2015)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
по: Lucy Matthews, и др.
Опубликовано: (2015-01-01)

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
по: Romain Marignier, и др.
Опубликовано: (2010-09-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
по: Viegas, S, и др.
Опубликовано: (2009)

Seasonal pattern of variation in neuromyelitis optica relapses
по: Elsone, L, и др.
Опубликовано: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
по: Jarius, S, и др.
Опубликовано: (2007)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
по: Luppe, S, и др.
Опубликовано: (2012)

Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica
по: Laurie Baert, и др.
Опубликовано: (2021-08-01)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
по: Achim Berthele, и др.
Опубликовано: (2023-04-01)

Racial differences in neuromyelitis optica spectrum disorder
по: Kim, S, и др.
Опубликовано: (2018)